☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
hiv
PharmaShots Interview: ViiV Healthcare’s Kimberly Smith Shares Insights on Apretude for the Prevention of HIV
April 26, 2022
Gilead Reports Interim Results of Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) in BICSTaR Study to Treat HIV
November 1, 2021
ViiV Healthcare Presents Three-Year Results of Dovato (dolutegravir/lamivudine) in P-III TANGO Study for the Treatment of HIV at I...
September 29, 2021
ViiV Healthcare Signs an Exclusive License Agreement with Shionogi to Develop S-365598 for HIV
September 28, 2021
Merck Presents Results from P-IIa Clinical Trial of Islatravir (MK-8591) for the Prevention of HIV at IAS 2021
July 21, 2021
Gilead Reports New Data of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV
July 19, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.